Good News | Warm Congratulations to Meisaitai Biotechnology on its inclusion in the "Hefei Biomedical 2023 Key Industry Chain Enterprise Recognition List"

  On March 28th, the Development and Reform Commission of Hefei City announced the "Hefei Biopharmaceutical 2023 Key Industry Chain Enterprise Identification List", and Anhui Meisaitai Biotechnology Co., Ltd. was included in the list. Congratulations!

  The identification of key industrial chain enterprises is an important link in the implementation of talent policies in key industries in Hefei, aiming to promote the implementation of industrial talent policies and further attract outstanding talents to support the development of key industries.

  As a new entrant to the IVD industry, Meisaitai Biotechnology is mainly engaged in the research and development and production of core raw materials for IVD, and provides a one-stop service system for the entire lifecycle of downstream enterprises in the industry. The successful recognition marks the government's recognition and recognition of Meisaitai Biotechnology's research and innovation capabilities in the IVD field. At the same time, it can also attract excellent talents for the company and provide more powerful assistance in promoting its future development. Meisaitai Biotechnology will use this industry chain platform, with innovation as its foothold, to continuously deepen its efforts in the IVD field and promote the development of the IVD and even the entire biopharmaceutical industry.